Spectral Medical Inc.
EDTXF
$0.96
$0.011.30%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 60.74% | -40.54% | 33.14% | 70.71% | -19.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.74% | -40.54% | 33.14% | 70.71% | -19.56% |
| Cost of Revenue | 15.97% | -42.63% | -7.98% | -41.52% | -32.78% |
| Gross Profit | 100.00% | -37.92% | 162.80% | 2,566.01% | -2.88% |
| SG&A Expenses | 0.74% | -12.15% | 3.07% | -27.78% | 53.74% |
| Depreciation & Amortization | 8.04% | 43.01% | 2.94% | -95.10% | -63.98% |
| Other Operating Expenses | -10.71% | 170.98% | -72.05% | -- | 561.80% |
| Total Operating Expenses | 1.63% | -12.58% | -1.65% | -35.18% | 40.35% |
| Operating Income | 7.74% | 5.37% | 7.51% | 46.38% | -59.12% |
| Income Before Tax | 75.96% | -190.20% | -200.36% | 56.57% | -184.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 75.96% | -190.20% | -200.36% | 56.57% | -184.79% |
| Earnings from Discontinued Operations | -4.76% | 100.00% | -- | -- | 4.55% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.95% | -190.32% | -200.36% | 56.57% | -184.64% |
| EBIT | 7.74% | 5.37% | 7.51% | 46.38% | -59.12% |
| EBITDA | 7.91% | 5.56% | 7.78% | 46.55% | -60.18% |
| EPS Basic | 76.62% | -188.61% | -195.00% | 57.39% | -180.00% |
| Normalized Basic EPS | 76.68% | -22.00% | -215.95% | 56.94% | -179.71% |
| EPS Diluted | 76.62% | -188.61% | -195.00% | 57.39% | -180.00% |
| Normalized Diluted EPS | 76.68% | -22.00% | -215.95% | 56.94% | -179.71% |
| Average Basic Shares Outstanding | 2.98% | 2.91% | 1.87% | 1.73% | 1.89% |
| Average Diluted Shares Outstanding | 2.98% | 2.91% | 1.87% | 1.73% | 1.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |